Gilotrif

DRUG3 trials

Sponsors

University of Alabama at Birmingham, Samsung Medical Center, Seoul St. Mary's Hospital

Conditions

NSCLCNon-small Cell Lung CancerPenile Squamous Cell Carcinoma (PSCC)

Phase 2

Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma

TerminatedNCT02541903

University of Alabama at BirminghamPenile Squamous Cell Carcinoma (PSCC)

Start: 2015-10-31End: 2020-04-30Updated: 2020-04-14

Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib

CompletedNCT02747953

Samsung Medical CenterNon-small Cell Lung Cancer

Start: 2011-07-31End: 2016-11-30Updated: 2021-03-19

Unknown Phase

Retrospective Multi-cohort Study of Frontline Afatinib Followed by 2nd Line Therapy Including Osimertinib, Chemotherapy or Other Therapy

Seoul St. Mary's HospitalNSCLC

Start: 2020-02-24End: 2021-09-30Updated: 2021-06-18

Related Papers

Pan-HER tyrosine-kinase inhibitors (TKI) dacomitinib and afatinib in penile squamous cell carcinoma (PSCC): Results from an ongoing open-label, single-group, phase 2 trial of dacomitinib in chemonaive patients (pts).

Journal of Clinical Oncology2016-01-10